Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Kimberly Bullock Gatling, a director at Culp Inc (CULP), purchased 1,812 shares on March 26, 2026, at $2.97 per share for a total of $5,381. The purchase occurred with the stock trading near its 52-week low and shortly after the company reported third-quarter fiscal 2026 results that missed analyst expectations on both earnings and revenue.
Mexico's main stock index ended the session in negative territory, dragged lower by losses in industrials and consumer-related sectors. Market breadth favored decliners, while commodity and FX moves showed notable strength in gold, oil and the US dollar against the peso and euro-peso crosses at the close.
Electra Battery Materials Corporation announced a successful recapitalization and the restart of construction on its cobalt sulfate refinery in Ontario, with a $73 million board-approved budget targeting mechanical completion in mid-2027 and commercial production by late 2027. The company strengthened its balance sheet via debt-to-equity conversion…
American Healthcare REIT executive Mark E. Foster carried out share sales and conversions on March 25, 2026 under a previously adopted Rule 10b5-1 plan and tax-covering actions, while the company reported fourth-quarter 2025 results that surpassed analyst expectations and put in place an at-the-market equity offering allowing for up to $1.75 billio…
Zevia PBC Chief Financial Officer Satya Girish sold 41,662 shares of Class A Common Stock on March 25, 2026 to satisfy tax obligations tied to restricted stock units, while the company reported mixed fourth-quarter 2025 results and announced a multi-year partnership with artist Cardi B. The insider sale occurred as the stock traded near its 52-week…
Colombia's benchmark index ended the session lower, with the COLCAP slipping 0.93% as losses in Financials, Investment and Public Services weighed on the market. Several large caps posted notable moves: Celsia SA and Interconnection Electric SA ESP were among the session's gainers, while Bancolombia Pf and Grupo Cibest SA were the largest decliners…
United Therapeutics Chairperson and CEO Martine Rothblatt executed an option exercise for 9,500 shares and sold those shares the same day under a pre-arranged 10b5-1 plan, generating roughly $5.09 million in proceeds. The transactions occurred March 26, 2026. Separately, the company announced positive phase 3 TETON-2 results for nebulized Tyvaso in…
Phreesia Chief Financial Officer Balaji Gandhi sold 3,829 shares of common stock on March 25, 2026, at a weighted average price of $11.2635, generating $43,127 to satisfy tax withholding on restricted stock units. The transaction coincides with a refinancing of the companys bridge loan into a $275 million senior secured revolving credit facility a…
Ryan Goepel, President and Chief Financial Officer of Global Crossing Airlines Group Inc (JETMF), executed three separate sales of common stock totaling 158,929 shares between February 20, 2026, and March 23, 2026, generating proceeds of $73,259. The transactions were reported on a Form 4 filed with the Securities and Exchange Commission. After the…
Ondas has pivoted from niche commercial drones into a nascent defense platform through acquisitions (World View, BIRD), partnerships (Palantir, Heidelberg) and a sizable cash injection. Management now guides to at least $375M in 2026 revenue after a Q4 2025 quarter of $30.1M (up 629% YoY). The market cap is ~$4.08B; the stock is volatile and techni…
Russian equities ended the trading session lower, with losses concentrated in Mining, Power and Oil & Gas names. The MOEX Russia Index fell 1.31% as decliners outpaced advancers by a wide margin. Volatility measures rose and key commodity contracts pushed higher, while the ruble moved modestly against major currencies.
United Therapeutics Chief Financial Officer and Treasurer Edgemond James sold $5.36 million of company stock on March 26, 2026, while exercising stock options for 10,000 shares the same day. The trades were executed under a Rule 10b5-1 plan. The company has also announced a $2 billion repurchase program and reported that its phase 3 TETON-2 study o…
Tyra Biosciences director Gilla Kaplan executed a series of option exercises and subsequent stock sales on March 25-26, 2026, realizing proceeds of roughly $2.54 million while retaining a stake in the company. The transactions coincide with a recent block sale of 4,000,000 shares that raised $126 million for the company and with sustained analyst s…
Kimberly D. Campos, who serves as Chief Information Officer and Chief Accounting Officer at Universal Insurance Holdings, sold 879 shares on March 26, 2026, realizing $29,745. The company recently reported fourth-quarter 2025 results that included an EPS of $2.17, materially above analyst expectations, while revenue came in marginally below forecas…
Okta Chief Revenue Officer Jonathan James Addison sold 23,304 shares of Class A common stock on March 25, 2026, for about $1.8 million under a pre-established Rule 10b5-1 plan. The trades took place at prices between $77.1011 and $78.653 per share. The stock's market quote sits at $73.21, near a 52-week low of $68.77, while InvestingPro’s Fair Valu…
Sean P. Downes, Executive Chairman of Universal Insurance Holdings (NASDAQ: UVE), sold 20,000 shares on March 25, 2026, for $692,072 at a weighted average price of $34.6036. The transaction occurred as the stock trades at a P/E of 5.34 and has returned 53% over the past year. Universal Insurance reported fourth-quarter 2025 EPS of $2.17, well ahead…
Karen Sykes, President and CMO of DD'S DISCOUNTS at Ross Stores, sold 5,506 shares on March 25, 2026, for $213.4006 per share, a transaction valued at $1,174,983. The sale occurred while the share price trades close to a 52-week high and after the company reported better-than-expected fourth-quarter fiscal 2025 results and signalled an aggressive s…
Cardinal Infrastructure Group Inc. (NASDAQ: CDNL) director Zelman Ivy purchased 6,921 shares on March 26, 2026, at a weighted average price of $36.33, a transaction totaling $251,439. The trade occurred as the stock trades near its 52-week high and follows robust quarterly revenue growth and a regional leadership appointment.
Manhattan Bridge Capital, Inc., a Nasdaq-listed firm specializing in short-term secured real estate loans, reported net income of approximately $5.11 million for 2025, down 8.6% from 2024 due to lower interest income and a decrease in loan originations. Revenue declined by 10.6% reflecting a contraction in loans receivable and slowed loan originati…
Biodexa Pharmaceuticals PLC, a NASDAQ-listed clinical-stage biopharmaceutical company specializing in gastrointestinal cancers, announced its audited preliminary results for the year ended December 31, 2025. Key developments include progress in the Phase 3 Serenta trial of eRapa for Familial Adenomatous Polyposis, initiation of a Phase 2a study of …
A federal judge has permitted two class-action lawsuits to proceed against Colgate-Palmolive, concluding that the company’s mouth rinse packaging may mislead parents into believing the products are safe for children under six. A separate claim over Colgate toothpaste was dismissed because its labeling included explicit instructions for young childr…
BKV Corp Chief Financial Officer David Tameron sold 7,300 shares of common stock on March 27, 2026, in multiple transactions that averaged $29.71 per share. The sale, executed under a pre-established Rule 10b5-1 trading plan, raised $216,918 and leaves Tameron with 61,925 shares. The transaction comes as BKV reports solid fourth-quarter results, an…
Yesway has refiled for a U.S. initial public offering, reviving plans it suspended in late 2022. The Fort Worth, Texas-based convenience store operator reported stronger profitability and higher revenue year-over-year and intends to list on the Nasdaq under the ticker YSWY. The filing comes as global market volatility and U.S. consumer affordabilit…
Director Charles Thomas McMillen sold 30,000 shares of Castellum, Inc. (OTC:CTM) on March 25, 2026, for $21,129, according to a Form 4 filing. The transaction follows a recent share-price decline and leaves McMillen with 231,015 shares. Separately, the company has retired $400,000 of debt, increased cash to over $14 million, and its subsidiary Spec…
Corcept Therapeutics Chief Executive Officer Joseph K. Belanoff sold 26,198 shares on March 25, 2026, generating about $1.3 million in proceeds under a Rule 10b5-1 plan. The company recently secured FDA approval for Lifyorli and received an analyst upgrade, even as its stock has fallen and a securities class action was filed.
